Results 211 to 220 of about 5,894,644 (362)

Author Correction: Accurate molecular recognition from the lowest unoccupied molecular orbital. [PDF]

Sci Rep
Zhou X, Yang S, Han C.
europepmc   +1 more source

Molecular Recognition by Crystalline Dipeptides

, 1994
Katsuyuki Ogura
openalex   +2 more sources

The Human Mismatch Recognition Complex hMSH2-hMSH6 Functions as a Novel Molecular Switch [PDF]

, 1997
Scott Gradia, Samir Acharya, Richard Fishel   +2 more
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Development of A Novel EvaGreen-Dye Based Recombinase Aided Amplification Assay Using Self-Avoiding Molecular Recognition System Primers. [PDF]

China CDC Wkly
Shen X, Hua S, Zhao Z, Tian F, Li L, Ma X.   +5 more
europepmc   +1 more source

Preferential molecular recognition of heterochiral guests within a cyclophane receptor. [PDF]

Nat Commun, 2023
Weh M, Shoyama K, Würthner F.
europepmc   +1 more source

Novel approaches to molecular recognition of ionic and neutral species by using membranes.

, 1990
Masao Sugawara, Kazunori Odashima, Yoshio Umezawa   +2 more
openalex   +2 more sources

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

Molecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint‐Lahat, Shlomit Gilad, Dana Morzaev‐Sulzbach, Anjana Shenoy, Noa Bossel Ben‐Moshe, Anya Pavlovsky, Rinat Bernstein‐Molho, Eytan Domany, Iris Barshack, Tamar Geiger, Bella Kaufman, Einav Nili Gal‐Yam   +14 more
wiley   +1 more source

Molecular Recognition in Confined Space Elucidated with DNA Nanopores and Single-Molecule Force Microscopy. [PDF]

Nano Lett, 2023
Suh SH, Xing Y, Rottensteiner A, Zhu R, Oh YJ, Howorka S, Hinterdorfer P.   +6 more
europepmc   +1 more source

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

Molecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez, Pablo Juanes‐Velasco, Marina L. García‐Vaquero, Conrad Droste, Alicia Landeira‐Viñuela, Miguel Alcoceba, Helena Fidalgo‐Gómez, Sara Misiego‐Herrero, Almudena Navarro‐Bailón, Mónica Baile, José M. Bastida, Jose Manuel Sanchez‐Santos, Rafael Góngora, Julia Almeida, Marcos Gonzalez‐Diaz, Alberto Orfao, Javier De Las Rivas, Manuel Fuentes   +17 more
wiley   +1 more source